CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 92(Granted Patents)

Company Filing History:

12 out of 544

Albemarle Corporation

Albermarle Corporation

patents

Years Active: 1988-2019

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10391072 - High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms (2019-08-27),

2. 9629809 - High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms (2017-04-25),

3. 9629806 - High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms (2017-04-25),

4. 8940329 - High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms (2015-01-27),

5. 6357678 - Process for producing ultra finely-divided zeolite powder (2002-03-19),

6. 6352966 - Cleansing bars (2002-03-05),

7. 6281176 - Process for producing betaine/amine oxide mixtures (2001-08-28),

8. 6231659 - Sizing agents and starting materials for their preparation (2001-05-15),

9. 6225475 - Enhanced production of hydrocarbyl anhydrides (2001-05-01),

10. 6225437 - Sizing agents of enhanced performance capabilities (2001-05-01),

11. 6221835 - High density zeolites and their production (2001-04-24),

12. 6035869 - Dish-washing method (2000-03-14),

13. 6010996 - Biocidal surfactant compositions and their use (2000-01-04),

14. 5922669 - No-rub hard surface cleaner comprising an alcohol ethoxylate-amine oxide (1999-07-13),

15. 5562866 - Formulated branched chain alcohol ether sulfate compounds (1996-10-08),

Title: The Innovative Contributions of Patrick C. Hu

Introduction

Patrick C. Hu, a prominent inventor based in Baton Rouge, LA, has made significant strides in the field of pharmaceuticals, holding an impressive portfolio of 23 patents. His work primarily revolves around the formulation and preparation of advanced pharmaceutical compounds, particularly those utilizing sodium ibuprofen.

Latest Patents

Among his latest inventions are groundbreaking patents concerning high-content sodium ibuprofen granules. These granules, formed from racemic sodium ibuprofen dihydrate, boast exceptional properties that facilitate their use in conventional rotary press tableting equipment without the operational difficulties typically encountered in practice. Hu's patent details the wet granulation process for their preparation, including the formulations suitable for creating solid dosage forms, solid dosage forms themselves, and methods for their preparation using a rotary press.

Career Highlights

Throughout his career, Patrick C. Hu has been associated with notable companies such as Albemarle Corporation and Ethyl Corporation, where he utilized his expertise to advance pharmaceutical innovation. His contributions have had a lasting impact on the field, optimizing medication formulations for improved patient outcomes.

Collaborations

In his professional journey, Hu has collaborated with distinguished colleagues like Conrad J. Langlois, Jr. and Joe D. Sauer. These partnerships have likely enriched his research, fostering a collaborative environment conducive to innovation.

Conclusion

With a robust patent portfolio and a history of impactful collaborations, Patrick C. Hu exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of sodium ibuprofen granules stand as a testament to his dedication to enhancing medication delivery and efficacy, showcasing the vital role of inventors in shaping modern healthcare.

This text is generated by artificial intelligence and may not be accurate.